ROFI, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 2.383
AS - Asia 998
EU - Europa 895
SA - Sud America 129
AF - Africa 93
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 4.516
Nazione #
US - Stati Uniti d'America 2.315
SG - Singapore 386
IT - Italia 331
CN - Cina 304
HK - Hong Kong 137
SE - Svezia 124
BR - Brasile 107
DE - Germania 93
GB - Regno Unito 93
BG - Bulgaria 78
CI - Costa d'Avorio 58
VN - Vietnam 54
CA - Canada 48
AT - Austria 33
FR - Francia 32
RU - Federazione Russa 30
TR - Turchia 23
IN - India 22
JP - Giappone 18
FI - Finlandia 16
NL - Olanda 15
SN - Senegal 13
PL - Polonia 11
BD - Bangladesh 10
ES - Italia 9
AU - Australia 8
EU - Europa 8
MX - Messico 8
NG - Nigeria 8
BE - Belgio 7
KR - Corea 7
LT - Lituania 7
AR - Argentina 5
CZ - Repubblica Ceca 4
IQ - Iraq 4
JM - Giamaica 4
PK - Pakistan 4
VE - Venezuela 4
ZA - Sudafrica 4
EC - Ecuador 3
KE - Kenya 3
LV - Lettonia 3
MA - Marocco 3
PA - Panama 3
SA - Arabia Saudita 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CH - Svizzera 2
CO - Colombia 2
IL - Israele 2
JO - Giordania 2
LK - Sri Lanka 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RO - Romania 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
TH - Thailandia 1
Totale 4.516
Città #
Ashburn 287
Fairfield 233
Woodbridge 218
Singapore 167
Houston 163
Santa Clara 156
Chandler 139
Hong Kong 137
Seattle 112
Cambridge 82
Serra 78
Sofia 78
Wilmington 78
Dallas 75
Ann Arbor 72
Shanghai 67
New York 63
Abidjan 58
Beijing 57
London 57
Pisa 56
Boardman 53
Florence 45
Princeton 42
Frankfurt am Main 36
Los Angeles 33
Ottawa 33
Lawrence 31
Vienna 30
Medford 23
Istanbul 19
Nanjing 19
Dearborn 18
Munich 18
Des Moines 16
Dong Ket 15
Boulder 14
Rome 14
Buffalo 13
Dakar 13
Redondo Beach 13
Chiesina Uzzanese 11
Fuzhou 11
Tokyo 11
Ho Chi Minh City 10
Turku 10
Washington 10
Phoenix 9
Redwood City 9
San Diego 9
Hefei 8
Lagos 8
Nuremberg 8
San Francisco 8
Warsaw 8
Chicago 7
Columbus 7
Kunming 7
Milan 7
São Paulo 7
Bremen 6
Brussels 6
Changsha 6
Guangzhou 6
Iowa City 6
Düsseldorf 5
Hyderabad 5
Lauterbourg 5
Ogden 5
Toronto 5
Turin 5
Belo Horizonte 4
Brasília 4
Brooklyn 4
Hanoi 4
Kilburn 4
Kingston 4
Montreal 4
Paris 4
Quanzhou 4
Chengdu 3
Council Bluffs 3
Fortaleza 3
Genoa 3
Hebei 3
Jiaxing 3
Lancaster 3
Madrid 3
Mexico City 3
Montevideo 3
Monza 3
Nanchang 3
Norwalk 3
Perth 3
Pistoia 3
Porto Velho 3
Prague 3
Riga 3
Rio de Janeiro 3
San Jose 3
Totale 3.252
Nome #
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 309
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 182
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 178
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 176
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response 169
Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World 168
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 166
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 164
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 163
Clinical pharmacology of intravitreal anti-VEGF drugs 158
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment 154
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. 153
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 153
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report 143
null 142
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 139
From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 137
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel 137
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial 136
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? 135
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 135
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 133
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 132
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy 126
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 126
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 116
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 110
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells 106
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 103
Should CYP2D6 be genotyped when treating with tamoxifen? [Letter in reply] 86
Early changes in plasma levels of mutant KRAS DNA as a sensitive marker of response to chemotherapy in pancreatic cancer 84
Should CYP2D6 be genotyped when treating with tamoxifen? 63
null 60
Totale 4.642
Categoria #
all - tutte 15.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021157 0 0 0 0 0 0 19 14 42 15 30 37
2021/2022318 3 14 7 7 64 62 16 8 20 11 16 90
2022/2023587 59 85 45 32 49 60 1 40 148 5 61 2
2023/2024370 19 21 71 19 40 78 18 12 8 14 37 33
2024/20251.058 9 38 11 70 145 119 59 55 118 136 102 196
2025/2026645 78 120 70 135 167 75 0 0 0 0 0 0
Totale 4.642